Q4 2023 Mersana Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Mersana Therapeutics fourth-quarter 2023 conference call and webcast. (Operator Instructions) Please note this call is being recorded.
I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications.
Thank you, operator, and good morning, everyone.
Before we begin, please note that this call will contain forward-looking statements within the meaning of federal securities laws. These statements may include, but are not limited to, those relating to our platforms, product candidates, business strategy, clinical trial execution and results, business development efforts, and cash runway. Each of these forward-looking statements is subject to risks and uncertainties that could cause actual results to differ materially from those projected in such statements.
These risks and uncertainties are discussed in our quarterly report on Form 10-Q filed with the Securities
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |